GlassScriptPhysician profile
Joseph White
NPI 1245483650
$1,314.32
in general payments reported to CMS, 2019-2025
11 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $335 · 2024: $509 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $902 · Education: $413.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $901.54 |
| Education | $412.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $368.07 | 2024-2025 | |
| Genzyme Corporation | $311.13 | 2023-2024 | |
| Incyte Corporation | $220.57 | 2025 | Opzelura |
| Janssen Biotech, INC. | $199.98 | 2023-2024 | Tremfya |
| Sanofi-Aventis U.S. LLC | $72.00 | 2023 | |
| Pfizer INC. | $45.81 | 2024 | |
| Regeneron Pharmaceuticals, INC. | $36.51 | 2024 | Dupixent |
| Merz North America, INC. | $19.53 | 2023 | Xeomin |
| Regeneron Healthcare Solutions, INC. | $17.36 | 2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $15.49 | 2025 | |
| Organon LLC | $7.87 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.